Advertisement
Research Article| Volume 86, ISSUE 2, P134-146, February 2023

Metabolic switching and cell wall remodelling of Mycobacterium tuberculosis during bone tuberculosis

  • Author Footnotes
    1 Present Address: Division of Bone and Mineral Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
    Khushpreet Kaur
    Footnotes
    1 Present Address: Division of Bone and Mineral Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
    Affiliations
    Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India
    Search for articles by this author
  • Author Footnotes
    2 These authors contributed equally to this work.
    Sumedha Sharma
    Footnotes
    2 These authors contributed equally to this work.
    Affiliations
    Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India
    Search for articles by this author
  • Author Footnotes
    2 These authors contributed equally to this work.
    Sudhanshu Abhishek
    Footnotes
    2 These authors contributed equally to this work.
    Affiliations
    Department of Biochemistry and Molecular Biology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States
    Search for articles by this author
  • Prabhdeep Kaur
    Affiliations
    Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India
    Search for articles by this author
  • Uttam Chand Saini
    Affiliations
    Department of Orthopaedics, Postgraduate Institute of Medical Education and Research, Chandigarh, India
    Search for articles by this author
  • Mandeep Singh Dhillon
    Affiliations
    Department of Orthopaedics, Postgraduate Institute of Medical Education and Research, Chandigarh, India
    Search for articles by this author
  • Petros C. Karakousis
    Affiliations
    Centers for Tuberculosis Research and Systems Approaches for Infectious Diseases, School of Medicine, Johns Hopkins University, Baltimore, MD, United States
    Search for articles by this author
  • Indu Verma
    Correspondence
    Corresponding author.
    Affiliations
    Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India
    Search for articles by this author
  • Author Footnotes
    1 Present Address: Division of Bone and Mineral Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
    2 These authors contributed equally to this work.
Published:December 19, 2022DOI:https://doi.org/10.1016/j.jinf.2022.12.014
Metabolic switching and cell wall remodelling of Mycobacterium tuberculosis during bone tuberculosis
Previous ArticleAll Staphylococcus aureus bacteraemia-inducing strains can cause infective endocarditis: Results of GWAS and experimental animal studies
Next ArticleImpact of the early phase of COVID-19 on the trends of isolated bacteria in the national database of Japan: an interrupted time-series analysis

      Highlights

      • •
        M.tb adapts to host environments primarily by alterations in its transcriptome.
      • •
        Remodelling of M.tb cell wall and metabolic pathways was seen in bone TB lesions.
      • •
        M.tb virulence genes were upregulated in bone lesions and cell line model.
      • •
        M.tb virulence proteins inhibit osteoblast differentiation, altering bone homeostasis.
      • •
        Further studies on the role of these proteins in bone TB needed using M.tb mutants.

      Abstract

      Objectives

      Bone tuberculosis (TB) is the third most common types of extrapulmonary tuberculosis. It is critical to understand mycobacterial adaptive strategies within bone lesions to identify mycobacterial factors that may have role in disease pathogenesis.

      Methods

      Whole genome microarray was used to characterize the in-vivo transcriptome of Mycobacterium tuberculosis (M.tb) within bone TB specimens. Mycobacterial virulent proteins were identified by bioinformatic software. An in vitro osteoblast cell line model was used to study the role of these proteins in bone TB pathogenesis.

      Results

      914 mycobacterial genes were significantly overexpressed and 1688 were repressed in bone TB specimens. Pathway analysis of differentially expressed genes demonstrated a non-replicative and hypometabolic state of M.tb, reinforcement of the mycobacterial cell wall and induction of DNA damage repair responses, suggesting possible survival strategies of M.tb within bone. Bioinformatics mining of microarray data led to identification of five virulence proteins. The genes encoding these proteins were also upregulated in the in vitro MC3T3 osteoblast cell line model of bone TB. Further, exposure of osteoblast cells to two of these virulence proteins (Rv1046c and Rv3663c) significantly inhibited osteoblast differentiation.

      Conclusion

      M.tb alters its transcriptome to establish infection in bone by upregulating certain virulence genes which play a key role in disturbing bone homeostasis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Donoghue H.D.
        • Lee O.Y.
        • Minnikin D.E.
        • Besra G.S.
        • Taylor J.H.
        • Spigelman M.
        Tuberculosis in Dr Granville's mummy: a molecular re-examination of the earliest known Egyptian mummy to be scientifically examined and given a medical diagnosis.
        Proc Biol Sci. 2010; 277 (Jan 7Epub 2009 Sep 30. PMID:19793751; PMCID: PMC2842630): 51-56https://doi.org/10.1098/rspb.2009.1484
        View in Article
        • Kanade S.
        • Nataraj G.
        • Mehta P.
        • Shah D.
        Pattern of missing probes in rifampicin resistant TB by Xpert MTB/RIF assay at a tertiary care centre in Mumbai.
        Indian J Tuberc. 2019; 66 (JanEpub 2018 Sep 6. PMID:30797272): 139-143https://doi.org/10.1016/j.ijtb.2018.08.002
        View in Article
        • Rajasekaran S.
        • Soundararajan D.C.R.
        • Shetty A.P.
        • Kanna R.M.
        Spinal Tuberculosis: current Concepts.
        Global Spine J. 2018; 8 (DecEpub 2018 Dec 13. PMID:30574444; PMCID: PMC6295815): 96S-108Shttps://doi.org/10.1177/2192568218769053
        View in Article
        • Jain A.K.
        Tuberculosis of the spine: a fresh look at an old disease.
        J Bone Joint Surg Br. 2010; 92 (JulPMID:20595106): 905-913https://doi.org/10.1302/0301-620X.92B7.24668
        View in Article
        • Jain A.K.
        • Rajasekaran S.
        Tuberculosis of the spine.
        Indian J Orthop. 2012; 46 (MarPMID:22448048; PMCID: PMC3308651): 127-129https://doi.org/10.4103/0019-5413.93671
        View in Article
        • Tsumura M.
        • Miki M.
        • Mizoguchi Y.
        • Hirata O.
        • Nishimura S.
        • Tamaura M.
        • Kagawa R.
        • Hayakawa S.
        • Kobayashi M.
        • Okada S.
        Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-γ.
        J Allergy Clin Immunol. 2022; 149 (Jane6Epub 2021 Jun 24. PMID:34176646): 252-261https://doi.org/10.1016/j.jaci.2021.05.018
        View in Article
        • Hoshino A.
        • Hanada S.
        • Yamada H.
        • Mii S.
        • Takahashi M.
        • Mitarai S.
        • Yamamoto K.
        • Manome Y.
        Mycobacterium tuberculosis escapes from the phagosomes of infected human osteoclasts reprograms osteoclast development via dysregulation of cytokines and chemokines.
        Pathog Dis. 2014; 70 (FebEpub 2013 Sep 10. PMID:23929604): 28-39https://doi.org/10.1111/2049-632X.12082
        View in Article
        • Jabir R.A.
        • Rukmana A.
        • Saleh I.
        • Kurniawati T.
        The existence of Mycobacterium tuberculosis in microenvironment of bone.
        (editor)in: Ribon W. Mycobacterium - Research and Development. IntechOpen, London2017https://doi.org/10.5772/intechopen.69394 ([Internet])
        View in Article
        • Sharma S.
        • Ryndak M.B.
        • Aggarwal A.N.
        • Yadav R.
        • Sethi S.
        • Masih S.
        • Laal S.
        • Verma I.
        Transcriptome analysis of mycobacteria in sputum samples of pulmonary tuberculosis patients.
        PLoS ONE. 2017; 12 (Mar 10PMID:28282458; PMCID: PMC5345810)e0173508https://doi.org/10.1371/journal.pone.0173508
        View in Article
        • Abhishek S.
        • Saikia U.N.
        • Gupta A.
        • Bansal R.
        • Gupta V.
        • Singh N.
        • Laal S.
        • Verma I.
        Transcriptional profile of Mycobacterium tuberculosis in an in vitro model of intraocular tuberculosis.
        Front Cell Infect Microbiol. 2018; 8 (Oct 2PMID:30333960; PMCID: PMC6175983): 330https://doi.org/10.3389/fcimb.2018.00330
        View in Article
        • Hudock T.A.
        • Foreman T.W.
        • Bandyopadhyay N.
        • Gautam U.S.
        • Veatch A.V.
        • LoBato D.N.
        • et al.
        Hypoxia sensing and persistence genes are expressed during the intragranulomatous survival of Mycobacterium tuberculosis.
        Am J Respir Cell Mol Biol. 2017; 56 (MayPMID:28135421; PMCID: PMC5449490): 637-647https://doi.org/10.1165/rcmb.2016-0239OC
        View in Article
        • Rachman H.
        • Strong M.
        • Ulrichs T.
        • Grode L.
        • Schuchhardt J.
        • Mollenkopf H.
        • et al.
        Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis.
        Infect Immun. 2006; 74 (FebPMID:16428773; PMCID: PMC1360294): 1233-1242https://doi.org/10.1128/IAI.74.2.1233-1242.2006
        View in Article
        • Rustad T.R.
        • Harrell M.I.
        • Liao R.
        • Sherman D.R.
        The enduring hypoxic response of Mycobacterium tuberculosis.
        PLoS ONE. 2008; 3 (Jan 30PMID:18231589; PMCID: PMC2198943): e1502https://doi.org/10.1371/journal.pone.0001502
        View in Article
        • Betts J.C.
        • Lukey P.T.
        • Robb L.C.
        • McAdam R.A.
        • Duncan K.
        Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling.
        Mol Microbiol. 2002; 43 (FebPMID:11929527): 717-731https://doi.org/10.1046/j.1365-2958.2002.02779.x
        View in Article
        • Karp P.D.
        • Billington R.
        • Caspi R.
        • Fulcher C.A.
        • Latendresse M.
        • Kothari A.
        • et al.
        The BioCyc collection of microbial genomes and metabolic pathways.
        Brief Bioinform. 2019; 20 (Jul 19PMID:29447345; PMCID: PMC6781571): 1085-1093https://doi.org/10.1093/bib/bbx085
        View in Article
        • Garg A.
        • Gupta D.
        VirulentPred: a SVM based prediction method for virulent proteins in bacterial pathogens.
        BMC Bioinform. 2008; 9 (Jan 28PMID:18226234; PMCID: PMC2254373): 62https://doi.org/10.1186/1471-2105-9-62
        View in Article
        • Sen T.
        • Verma N.K.
        Functional annotation and curation of hypothetical proteins present in a newly emerged serotype 1c of shigella flexneri: emphasis on selecting targets for virulence and vaccine design studies.
        Genes. 2020; 11 (Basel)Mar 23PMID:32210046; PMCID: PMC7141135: 340https://doi.org/10.3390/genes11030340
        View in Article
        • Hwang P.W.
        • Horton J.A.
        Variable osteogenic performance of MC3T3-E1 subclones impacts their utility as models of osteoblast biology.
        Sci Rep. 2019; 9 (Jun 5PMID:31165768; PMCID: PMC6549152): 8299https://doi.org/10.1038/s41598-019-44575-8
        View in Article
        • Maitra A.
        • Munshi T.
        • Healy J.
        • Martin L.T.
        • Vollmer W.
        • Keep N.H.
        • Bhakta S.
        Cell wall peptidoglycan in Mycobacterium tuberculosis: an Achilles' heel for the TB-causing pathogen.
        FEMS Microbiol Rev. 2019; 43 (Sep 1PMID:31183501; PMCID: PMC6736417): 548-575https://doi.org/10.1093/femsre/fuz016
        View in Article
        • Soni V.
        • Upadhayay S.
        • Suryadevara P.
        • Samla G.
        • Singh A.
        • Yogeeswari P.
        • et al.
        Depletion of M. tuberculosis GlmU from infected murine lungs effects the clearance of the pathogen.
        PLoS Pathog. 2015; 11 (Oct 21PMID:26489015; PMCID: PMC4619583)e1005235https://doi.org/10.1371/journal.ppat.1005235
        View in Article
        • Haufroid M.
        • Wouters J.
        Targeting the serine pathway: a promising approach against tuberculosis?.
        Pharmaceuticals. 2019; 12 (Basel)Apr 30PMID:31052291; PMCID: PMC6630544: 66https://doi.org/10.3390/ph12020066
        View in Article
        • Kohlmeier M.
        Serine.
        Nutrient Metabolism. Academic Press, 2003https://doi.org/10.1016/B978-012417762-8.50049-1 (ISBN 9780124177628)
        View in Article
        • Tiwari S.
        • Van Tonder A.J.
        • Vilcheze C.
        • Mendes V.
        • Thomas S.E.
        • Malek A.
        • et al.
        Arginine-deprivation-induced oxidative damage sterilizes Mycobacterium tuberculosis.
        Proc Natl Acad Sci U S A. 2018; 115 (Sep 25Epub 2018 Aug 24. PMID:30143580; PMCID: PMC6166831): 9779-9784https://doi.org/10.1073/pnas.1808874115
        View in Article
        • Mizrahi V.
        • Warner D.F.
        Death of Mycobacterium tuberculosis by L-arginine starvation.
        Proc Natl Acad Sci U S A. 2018; 115 (Sep 25Epub 2018 Sep 6. PMID:30190428; PMCID: PMC6166815): 9658-9660https://doi.org/10.1073/pnas.1813587115
        View in Article
        • Khan M.Z.
        • Kaur P.
        • Nandicoori V.K.
        Targeting the messengers: serine/threonine protein kinases as potential targets for antimycobacterial drug development.
        IUBMB Life. 2018; 70 (SepEpub 2018 Jun 22. PMID:29934969): 889-904https://doi.org/10.1002/iub.1871
        View in Article
        • Iswahyudi
        • Mukamolova GV
        • Straatman-Iwanowska A.A.
        • Allcock N.
        • Ajuh P.
        • Turapov O.
        • O'Hare H.M
        Mycobacterial phosphatase PstP regulates global serine threonine phosphorylation and cell division.
        Sci Rep. 2019; 9 (Jun 6PMID:31171861; PMCID: PMC6554272): 8337https://doi.org/10.1038/s41598-019-44841-9
        View in Article
        • Rieck B.
        • Degiacomi G.
        • Zimmermann M.
        • Cascioferro A.
        • Boldrin F.
        • Lazar-Adler N.R.
        • et al.
        PknG senses amino acid availability to control metabolism and virulence of Mycobacterium tuberculosis.
        PLoS Pathog. 2017; 13 (May 17PMID:28545104; PMCID: PMC5448819)e1006399https://doi.org/10.1371/journal.ppat.1006399
        View in Article
        • Dos Vultos T.
        • Mestre O.
        • Tonjum T.
        • Gicquel B
        DNA repair in Mycobacterium tuberculosis revisited.
        FEMS Microbiol Rev. 2009; 33 (MayPMID:19385996): 471-487https://doi.org/10.1111/j.1574-6976.2009.00170.x
        View in Article
        • Datta P.
        • Dasgupta A.
        • Singh A.K.
        • Mukherjee P.
        • Kundu M.
        • Basu J.
        Interaction between FtsW and penicillin-binding protein 3 (PBP3) directs PBP3 to mid-cell, controls cell septation and mediates the formation of a trimeric complex involving FtsZ, FtsW and PBP3 in mycobacteria.
        Mol Microbiol. 2006; 62 (DecPMID:17427288): 1655-1673https://doi.org/10.1111/j.1365-2958.2006.05491.x
        View in Article
        • Hett E.C.
        • Rubin E.J.
        Bacterial growth and cell division: a mycobacterial perspective.
        Microbiol Mol Biol Rev. 2008; 72 (Martable of contentsPMID:18322037; PMCID: PMC2268284): 126-156https://doi.org/10.1128/MMBR.00028-07
        View in Article
        • Prisic S.
        • Husson R.N.
        Mycobacterium tuberculosis serine/threonine protein kinases.
        Microbiol Spectr. 2014; 2 (OctPMID:25429354; PMCID: PMC4242435): 10https://doi.org/10.1128/microbiolspec.MGM2-0006-2013
        View in Article
        • Zheng F.
        • Long Q.
        • Xie J.
        The function and regulatory network of WhiB and WhiB-like protein from comparative genomics and systems biology perspectives.
        Cell Biochem Biophys. 2012; 63 (JunPMID:22388511): 103-108https://doi.org/10.1007/s12013-012-9348-z
        View in Article
        • Warner D.F.
        Mycobacterium tuberculosis metabolism.
        Cold Spring Harb Perspect Med. 2014; 5 (Dec 11PMID:25502746; PMCID: PMC4382733)a021121https://doi.org/10.1101/cshperspect.a021121
        View in Article
        • Dutta N.K.
        • Karakousis P.C.
        Latent tuberculosis infection: myths, models, and molecular mechanisms.
        Microbiol Mol Biol Rev. 2014; 78 (SepPMID:25184558; PMCID: PMC4187682): 343-371https://doi.org/10.1128/MMBR.00010-14
        View in Article
        • Hudson M.C.
        • Ramp W.K.
        • Frankenburg K.P.
        Staphylococcus aureus adhesion to bone matrix and bone-associated biomaterials.
        FEMS Microbiol Lett. 1999; 173 (Apr 15PMID:10227156): 279-284https://doi.org/10.1111/j.1574-6968.1999.tb13514.x
        View in Article
        • Jain A.K.
        Tuberculosis of the skeletal system.
        Indian J Orthop. 2016; 50 (PMCID: PMC4885308): 337
        View in Article
        • Liu W.
        • Zhou J.
        • Niu F.
        • Pu F.
        • Wang Z.
        • Huang M.
        • et al.
        Mycobacterium tuberculosis infection increases the number of osteoclasts and inhibits osteoclast apoptosis by regulating TNF-α-mediated osteoclast autophagy.
        Exp Ther Med. 2020; 20 (SepEpub 2020 Jun 18. PMID:32782497; PMCID: PMC7401307): 1889-1898https://doi.org/10.3892/etm.2020.8903
        View in Article
        • Sarkar S.
        • Dlamini M.G.
        • Bhattacharya D.
        • Ashiru O.T.
        • Sturm A.W.
        • Moodley P.
        Strains of Mycobacterium tuberculosis differ in affinity for human osteoblasts and alveolar cells in vitro.
        Springerplus. 2016; 5 (Feb 24PMID:27026860; PMCID: PMC4766163): 163https://doi.org/10.1186/s40064-016-1819-z
        View in Article
        • Hotokezaka H.
        • Kitamura A.
        • Matsumoto S.
        • Hanazawa S.
        • Amano S.
        • Yamada T.
        Internalization of Mycobacterium bovis Bacillus Calmette-Guérin into osteoblast-like MC3T3-E1 cells and bone resorptive responses of the cells against the infection.
        Scand J Immunol. 1998; 47 (MayPMID:9627129): 453-458https://doi.org/10.1046/j.1365-3083.1998.00318.x
        View in Article
        • Angala S.K.
        • Belardinelli J.M.
        • Huc-Claustre E.
        • Wheat W.H.
        • Jackson M.
        The cell envelope glycoconjugates of Mycobacterium tuberculosis.
        Crit Rev Biochem Mol Biol. 2014; 49 (Sep-OctEpub 2014 Jun 10. PMID:24915502; PMCID: PMC4436706): 361-399https://doi.org/10.3109/10409238.2014.925420
        View in Article
        • Vincent A.T.
        • Nyongesa S.
        • Morneau I.
        • Reed M.B.
        • Tocheva E.I.
        • Veyrier F.J.
        The mycobacterial cell envelope: a relict from the past or the result of recent evolution?.
        Front Microbiol. 2018; 9 (Oct 9PMID:30369911; PMCID: PMC6194230): 2341https://doi.org/10.3389/fmicb.2018.02341
        View in Article
        • Thanna S.
        • Sucheck S.J.
        Targeting the trehalose utilization pathways of Mycobacterium tuberculosis.
        Medchemcomm. 2016; 7 (Epub 2015 Oct 16. PMID:26941930; PMCID: PMC4770839): 69-85https://doi.org/10.1039/C5MD00376H
        View in Article
        • Korte J.
        • Alber M.
        • Trujillo C.M.
        • Syson K.
        • Koliwer-Brandl H.
        • Deenen R.
        • Kohrer K.
        • et al.
        Trehalose-6-phosphate-mediated toxicity determines essentiality of OtsB2 in Mycobacterium tuberculosis in vitro and in Mice.
        PLoS Pathog. 2016; 12 (Dec 9PMID:27936238; PMCID: PMC5148154)e1006043https://doi.org/10.1371/journal.ppat.1006043
        View in Article
        • Borah K.
        • Beyß M.
        • Theorell A.
        • Wu H.
        • Basu P.
        • Mendum T.A.
        • et al.
        Intracellular Mycobacterium tuberculosis exploits multiple host nitrogen sources during growth in human macrophages.
        Cell Rep. 2019; 29 (Dec 10e4PMID:31825837; PMCID: PMC6915324): 3580-3591https://doi.org/10.1016/j.celrep.2019.11.037
        View in Article
        • Mishra A.
        • Mamidi A.S.
        • Rajmani R.S.
        • Ray A.
        • Roy R.
        • Surolia A.
        An allosteric inhibitor of Mycobacterium tuberculosis ArgJ: implications to a novel combinatorial therapy.
        EMBO Mol Med. 2018; 10 (Apr): e8038https://doi.org/10.15252/emmm.201708038
        View in Article
        • Paritala H.
        • Carroll K.S.
        New targets and inhibitors of mycobacterial sulfur metabolism.
        Infect Disord Drug Targets. 2013; 13 (AprPMID:23808874; PMCID: PMC4332622): 85-115https://doi.org/10.2174/18715265113139990022
        View in Article
        • Sharma A.K.
        • Arora D.
        • Singh L.K.
        • Gangwal A.
        • Sajid A.
        • Molle V.
        • Singh Y.
        • Nandicoori V.K.
        Serine/threonine protein phosphatase PstP of Mycobacterium tuberculosis is necessary for accurate cell division and survival of pathogen.
        J Biol Chem. 2016; 291 (Nov 11Epub 2016 Oct 7. PMID:27758870; PMCID: PMC5104944): 24215-24230https://doi.org/10.1074/jbc.M116.754531
        View in Article
        • Hannon R.A.
        • Clowes J.A.
        • Eagleton A.C.
        • Al Hadari A.
        • Eastell R.
        • Blumsohn A
        Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
        Bone. 2004; 34 (JanPMID:14751577): 187-194https://doi.org/10.1016/j.bone.2003.04.002
        View in Article
        • Coker O.O.
        • Warit S.
        • Rukseree K.
        • Summpunn P.
        • Prammananan T.
        • Palittapongarnpim P.
        Functional characterization of two members of histidine phosphatase superfamily in Mycobacterium tuberculosis.
        BMC Microbiol. 2013; 13 (Dec 11PMID:24330471; PMCID: PMC3866925): 292https://doi.org/10.1186/1471-2180-13-292
        View in Article
        • Forrellad M.A.
        • Blanco F.C.
        • Marrero Diaz de Villegas R.
        • Vázquez C.L.
        • Yaneff A.
        • García E.A.
        • et al.
        Rv2577 of Mycobacterium tuberculosis is a virulence factor with dual phosphatase and phosphodiesterase functions.
        Front Microbiol. 2020; 11 (Oct 22PMID:33193164; PMCID: PMC7642983)570794https://doi.org/10.3389/fmicb.2020.570794
        View in Article
        • Žgur-Bertok D.
        DNA damage repair and bacterial pathogens.
        PLoS Pathog. 2013; 9 (Epub 2013 Nov 7. PMID:24244154; PMCID: PMC3820712)e1003711https://doi.org/10.1371/journal.ppat.1003711
        View in Article
        • Guo S.
        • Xue R.
        • Li Y.
        • Wang S.M.
        • Ren L.
        • Xu J.J.
        The CFP10/ESAT6 complex of Mycobacterium tuberculosis may function as a regulator of macrophage cell death at different stages of tuberculosis infection.
        Med Hypotheses. 2012; 78 (MarEpub 2011 Dec 21. PMID:22192908): 389-392https://doi.org/10.1016/j.mehy.2011.11.022
        View in Article
        • Forrellad M.A.
        • Klepp L.I.
        • Gioffré A.
        • Sabio y García J.
        • Morbidoni H.R.
        • de la Paz
        • Santangelo M.
        • Cataldi A.A.
        • Bigi F.
        Virulence factors of the Mycobacterium tuberculosis complex.
        Virulence. 2013; 4 (Jan 1Epub 2012 Oct 17. PMID:23076359; PMCID: PMC3544749): 3-66https://doi.org/10.4161/viru.22329
        View in Article
        • Le Nours J.
        • Bulloch E.M.
        • Zhang Z.
        • Greenwood D.R.
        • Middleditch M.J.
        • Dickson J.M.
        • Baker E.N
        Structural analyses of a purine biosynthetic enzyme from Mycobacterium tuberculosis reveal a novel bound nucleotide.
        J Biol Chem. 2011; 286 (Nov 25Epub 2011 Sep 28. PMID:21956117; PMCID: PMC3220471): 40706-40716https://doi.org/10.1074/jbc.M111.291138
        View in Article
        • Sassetti C.M.
        • Rubin E.J.
        Genetic requirements for mycobacterial survival during infection.
        Proc Natl Acad Sci U S A. 2003; 100 (Oct 28Epub 2003 Oct 20. PMID:14569030; PMCID: PMC240732): 12989-12994https://doi.org/10.1073/pnas.2134250100
        View in Article
        • Eoh H.
        • Rhee K.Y.
        Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis.
        Proc Natl Acad Sci U S A. 2013; 110 (Apr 16Epub 2013 Apr 1. PMID:23576728; PMCID: PMC3631649): 6554-6559https://doi.org/10.1073/pnas.1219375110
        View in Article
        • Ryndak M.B.
        • Singh K.K.
        • Peng Z.
        • Laal S.
        Transcriptional profiling of Mycobacterium tuberculosis replicating in the human type II alveolar epithelial cell line, A549.
        Genom Data. 2015; 5 (Sep 1PMID:26258047; PMCID: PMC4527333): 112-114https://doi.org/10.1016/j.gdata.2015.05.026
        View in Article
        • Becq J.
        • Gutierrez M.C.
        • Rosas-Magallanes V.
        • Rauzier J.
        • Gicquel B.
        • Neyrolles O.
        • Deschavanne P.
        Contribution of horizontally acquired genomic islands to the evolution of the tubercle bacilli.
        Mol Biol Evol. 2007; 24 (AugEpub 2007 Jun 1. PMID:17545187): 1861-1871https://doi.org/10.1093/molbev/msm111
        View in Article
        • Bai G.
        • McCue L.A.
        • McDonough K.A.
        Characterization of Mycobacterium tuberculosis Rv3676 (CRPMt), a cyclic AMP receptor protein-like DNA binding protein.
        J Bacteriol. 2005; 187 (NovPMID:16267303; PMCID: PMC1280308): 7795-7804https://doi.org/10.1128/JB.187.22.7795-7804.2005
        View in Article
        • Flores-Valdez M.A.
        • Morris R.P.
        • Laval F.
        • Daffé M.
        • Schoolnik G.K.
        Mycobacterium tuberculosis modulates its cell surface via an oligopeptide permease (Opp) transport system.
        FASEB J. 2009; 23 (DecEpub 2009 Aug 11. PMID:19671666; PMCID: PMC2812042): 4091-4104https://doi.org/10.1096/fj.09-132407
        View in Article
        • Mitra A.
        • Ko Y.H.
        • Cingolani G.
        • Niederweis M.
        Heme and hemoglobin utilization by Mycobacterium tuberculosis.
        Nat Commun. 2019; 10 (Sep 18PMID:31534126; PMCID: PMC6751184): 4260https://doi.org/10.1038/s41467-019-12109-5
        View in Article
        • Singh P.P.
        • Parra M.
        • Cadieux N.
        • Brennan M.J.
        A comparative study of host response to three Mycobacterium tuberculosis PE_PGRS proteins.
        Microbiology (Reading). 2008; 154 (NovPMID:18957600): 3469-3479https://doi.org/10.1099/mic.0.2008/019968-0
        View in Article
        • Kruh N.A.
        • Troudt J.
        • Izzo A.
        • Prenni J.
        • Dobos K.M.
        Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo.
        PLoS ONE. 2010; 5 (Nov 11PMID:21085642; PMCID: PMC2978697): e13938https://doi.org/10.1371/journal.pone.0013938
        View in Article
        • Buttery L.D.
        • Bourne S.
        • Xynos J.D.
        • Wood H.
        • Hughes F.J.
        • Hughes S.P.
        • Episkopou V.
        • Polak J.M.
        Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells.
        Tissue Eng. 2001; 7 (FebPMID:11224927): 89-99https://doi.org/10.1089/107632700300003323
        View in Article
        • Bando-Campos G.
        • Juárez-López D.
        • Román-González S.A.
        • Castillo-Rodal A.I.
        • Olvera C.
        • López-Vidal Y.
        • Arreguín-Espinosa R.
        • Espitia C.
        • Trujillo-Roldán M.A.
        • Valdez-Cruz N.A.
        Recombinant O-mannosylated protein production (PstS-1) from Mycobacterium tuberculosis in Pichia pastoris (Komagataella phaffii) as a tool to study tuberculosis infection.
        Microb Cell Fact. 2019; 18 (Jan 19PMID:30660186; PMCID: PMC6339365): 11https://doi.org/10.1186/s12934-019-1059-3
        View in Article
        • Sharma N.
        • Shariq M.
        • Quadir N.
        • Singh J.
        • Sheikh J.A.
        • Hasnain S.E.
        • Ehtesham N.Z.
        Mycobacterium tuberculosis Protein PE6 (Rv0335c), a Novel TLR4 agonist, evokes an inflammatory response and modulates the cell death pathways in macrophages to enhance intracellular survival.
        Front Immunol. 2021; 12 (Jul 12PMID:34322125; PMCID: PMC831149)696491https://doi.org/10.3389/fimmu.2021.696491
        View in Article
        • Palucci I.
        • Camassa S.
        • Cascioferro A.
        • Sali M.
        • Anoosheh S.
        • Zumbo A.
        • et al.
        PE_PGRS33 contributes to Mycobacterium tuberculosis entry in macrophages through interaction with TLR2.
        PLoS ONE. 2016; 11 (Mar 15PMID:26978522; PMCID: PMC4792380)e0150800https://doi.org/10.1371/journal.pone.0150800
        View in Article
        • Kwon Y.
        • Park C.
        • Lee J.
        • Park D.H.
        • Jeong S.
        • Yun C.H.
        • Park O.J.
        • Han S.H.
        Regulation of bone cell differentiation and activation by microbe-associated molecular patterns.
        Int J Mol Sci. 2021; 22 (May 28PMID:34071605; PMCID: PMC8197933): 5805https://doi.org/10.3390/ijms22115805
        View in Article
        • Bandow K.
        • Maeda A.
        • Kakimoto K.
        • Kusuyama J.
        • Shamoto M.
        • Ohnishi T.
        • Matsuguchi T.
        Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation.
        Biochem Biophys Res Commun. 2010; 402 (Nov 26Epub 2010 Oct 29. PMID:21036155): 755-761https://doi.org/10.1016/j.bbrc.2010.10.103
        View in Article
        • Chen M.F.
        • Chang C.H.
        • Hu C.C.
        • Wu Y.Y.
        • Chang Y.
        • Ueng S.W.N.
        Periprosthetic joint infection caused by gram-positive versus gram-negative bacteria: lipopolysaccharide, but not lipoteichoic acid, exerts adverse osteoclast-mediated effects on the bone.
        J Clin Med. 2019; 8 (Aug 23PMID:31450783; PMCID: PMC6780630): 1289https://doi.org/10.3390/jcm8091289
        View in Article

      Article info

      Publication history

      Published online: December 19, 2022
      Accepted: December 13, 2022

      Identification

      DOI: https://doi.org/10.1016/j.jinf.2022.12.014

      Copyright

      © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX